MDM2 and neoplasm: MDM2 SNP309 T/G has originally been reported to be associated with an increased risk for tumor formation in patients with an inherited mutated p53 allele (Li-Fraumeni syndrome) and in patients with sporadic soft tissue sarcoma [10].